Russia imports 75 percent of all medical equipment, which Coloplast highly benefits from, according to a recent newsletter from the Confederation of Danish Industry (DI).
The Danish medtech company has been active on the Russian market for 20 years, although it is disadvantaged by the fact that it has no production in the country, since Russian authorities give preferential treatment to local enterprises, which Coloplast General Director and Country Manager, Rus cluster, Dmitry Tsarapkin tells DI.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
CHMP to remove 100 generic medicines from market
Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.
Germany orders 40,000 monkeypox vaccines from Bavarian Nordic
The German Minister for Health has revealed that the German state has ordered vaccines from Bavarian Nordic, as the country reports 5 cases of monkeypox.
New head of research at Astellas Gene Therapies: "Choosing the right indications is extra important"
Morten Søgaard is leaving Pfizer to join Astellas, where he will be in charge of 100 employees. Going from one of the world largest pharmaceutical firms to a considerably smaller one will be a challenge, he says.
Rumored purchase of GN Group could mean divestment of hearing aid division, says media
Inside Business has learned that a number of buyers might be looking to buy GN Store Nord stock while it’s cheap, with the plan to sell one division, GN Hearing, while keeping Audio.
EMA publishes new plan to support antibiotic development
Drug-resistant bacteria kill hundreds of thousands of people every year, and national regulatory forces across the world are now coming together to ensure a uniform approach to clinical trials for antibiotics.
Clinical Trial Administrator 
Chemist for Incoming Materials in QC Department 
Key Account Manager, Europe and Asia 
Communications Consultant 
Senior Project Manager (GMP - Life Science) 
IRT Manager, Clinical Drug Supply 
Clinical Project Manager 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Innovation Project Manager, Display Unit 
Consultant Manager 
Nordic Medical Affairs Manager 
(Senior) Drug Substance Specialist 
Cell Culture Scientist/Senior Scientist 
Director for innovative pre-clinical testing unit